This topic contains a solution. Click here to go to the answer

Author Question: Advocacy leadership: a.Is critical to improving quality in the field of early care and ... (Read 59 times)

nramada

  • Hero Member
  • *****
  • Posts: 580
Advocacy leadership:
 
  a.Is critical to improving quality in the field of early care and educationb.Is not necessary in the field of early care and educationc.Does not help to improve facilities

Question 2

According to Bloom (1997), exemplary directors:
 
  a.Focus on the presentb.Focus on the futurec.Focus on the present and future simultaneously



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

vish98

  • Sr. Member
  • ****
  • Posts: 326
Answer to Question 1

ANSWER:
A

Answer to Question 2

ANSWER:
C




nramada

  • Member
  • Posts: 580
Reply 2 on: Jul 31, 2018
YES! Correct, THANKS for helping me on my review


at

  • Member
  • Posts: 359
Reply 3 on: Yesterday
Thanks for the timely response, appreciate it

 

Did you know?

Opium has influenced much of the world's most popular literature. The following authors were all opium users, of varying degrees: Lewis Carroll, Charles, Dickens, Arthur Conan Doyle, and Oscar Wilde.

Did you know?

A cataract is a clouding of the eyes' natural lens. As we age, some clouding of the lens may occur. The first sign of a cataract is usually blurry vision. Although glasses and other visual aids may at first help a person with cataracts, surgery may become inevitable. Cataract surgery is very successful in restoring vision, and it is the most frequently performed surgery in the United States.

Did you know?

Interferon was scarce and expensive until 1980, when the interferon gene was inserted into bacteria using recombinant DNA technology, allowing for mass cultivation and purification from bacterial cultures.

Did you know?

Excessive alcohol use costs the country approximately $235 billion every year.

Did you know?

For high blood pressure (hypertension), a new class of drug, called a vasopeptidase blocker (inhibitor), has been developed. It decreases blood pressure by simultaneously dilating the peripheral arteries and increasing the body's loss of salt.

For a complete list of videos, visit our video library